CpG Oligodeoxynucleotides as TLR9 Agonists: Therapeutic Applications in Cancer

ISSN： 1173-8804

Source： BioDrugs, Vol.23, Iss.6, 2009-12, pp. : 361-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CpG Oligodeoxynucleotides as TLR9 Agonists: Therapeutic Application in Allergy and Asthma

By Gupta Gaurav K. Agrawal Devendra K.

BioDrugs, Vol. 24, Iss. 4, 2010-08 ,pp. : 225-235

Adis International

Access to resources Recommend Favorite

Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation

By Jurk Marion Vollmer Jörg

BioDrugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 387-401

Adis International

Access to resources Recommend Favorite

CpG DNA in the Prevention and Treatment of Infections

By Dalpke A. Zimmermann S. Heeg K.

BioDrugs, Vol. 16, Iss. 6, 2002-01 ,pp. : 419-431

Adis International

Access to resources Recommend Favorite

The CpG Motif: Implications for Clinical Immunology

By Krieg A.M.

BioDrugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 341-346

Adis International

Access to resources Recommend Favorite

Therapeutic Ribozymes: Principles and Applications

By Rossi J.J.

BioDrugs, Vol. 9, Iss. 1, 1998-01 ,pp. : 1-10

Adis International

Access to resources Recommend Favorite